Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Other financing activities: 2010-2021

Historic Other financing activities for Prestige Consumer Healthcare (PBH) over the last 4 years, with Mar 2021 value amounting to $17.7 million.

  • Prestige Consumer Healthcare's Other financing activities rose 2139.95% to $17.7 million in Q1 2021 from the same period last year, while for Mar 2021 it was $19.3 million, marking a year-over-year increase of 1395.82%. This contributed to the annual value of $769,000 for FY2024, which is N/A change from last year.
  • Prestige Consumer Healthcare's Other financing activities amounted to $17.7 million in Q1 2021, which was up 2,139.95% from $791,000 recorded in Q1 2020.
  • Over the past 5 years, Prestige Consumer Healthcare's Other financing activities peaked at $17.7 million during Q1 2021, and registered a low of -$302,000 during Q2 2017.
  • Moreover, its 2-year median value for Other financing activities was $9.3 million (2020), whereas its average is $9.3 million.
  • Its Other financing activities has fluctuated over the past 5 years, first plummeted by 91.88% in 2018, then spiked by 2,139.95% in 2021.
  • Quarterly analysis of 4 years shows Prestige Consumer Healthcare's Other financing activities stood at -$168,000 in 2017, then plummeted by 91.88% to $970,000 in 2018, then reached $791,000 in 2020, then soared by 2,139.95% to $17.7 million in 2021.
  • Its last three reported values are $17.7 million in Q1 2021, $791,000 for Q1 2020, and $970,000 during Q1 2018.